Most of these pharmaceutical products are produced by Indian enterprises including Umedica Laboratories, Marksans Pharma, Yeva Therapeutics, Medicines Cure, and Medley Pharmaceuticals.
The DAV said it is intensifying inspection and drug quality testing before authorizing drugs to be sold on the market.
On this occasion, the Administration also stopped receiving registration dossiers of the US producer Robinson Pharma due to its extensive quality violations.
